OFC 2015: EMCORE to Highlight End-to-End DOCSIS 3.1 CATV Transmission Link

EMCORE Corporation, a leading provider of compound semiconductor-based components, subsystems and systems for the broadband and specialty fiber optics market, announced today that it will host a demonstration of its End-to-End DOCSIS 3.1 CATV transmission link capabilities at the Optical Fiber Conference (OFC) in Booth #608, March 24-26 at the Los Angeles Convention Center, Los Angeles, California.

A DOCSIS 3.1 compliant prototype of EMCORE's Medallion 6000 Series 1550 nm CATV Transmitter will be featured in the demonstration, along with the new Medallion 2100 Optical A/B Switch and Medallion 7100 CATV Fiber Amplifier transmitting over a 40 km fiber link to EMCORE's RFoG (Radio Frequency over Glass) Transceiver.

The Medallion 6000 externally-modulated transmitter, based on EMCORE's proprietary continuous wave laser technology, couples high optical output power up to 11.0 dBm, with low optical linewidth resulting in unmatched performance. The transmitter leverages proprietary pre-distortion circuitry to provide superior CTB and CSO performance with SBS suppression levels of greater than 21 dBm through 40 km of fiber. The Medallion 2100 Optical A/B Switch is a high-performance solution for network protection and optical redundancy in CATV/FTTx networks. Its automatic switching protects the network from inadvertent service outages due to up-stream optical signal degradation. EMCORE's Medallion 7100 Fiber Amplifier provides very stable optical outputs over a wide operating temperature range, as well as the exceptionally high power and low noise figures demanded by CATV applications. EMCORE's RFoG Transceiver is PON (Passive Optical Network) compatible and supports 1310/1590/1610 nm burst mode analog return-path, and digital or QAM upstream.

"Our end-to-end DOCSIS 3.1 demonstration at the OFC will show EMCORE's capabilities to deliver the highest quality video and audio, along with high-speed data transmission in a DOCSIS 3.1 compatible system," said Gyo Shinozaki, Director of Marketing for EMCORE's CATV products. "EMCORE's line of CATV components and systems will support Cable operators as they move to this latest DOCSIS standard for higher-speed data transfer over their existing CATV networks," added Shinozaki.

In addition at OFC, EMCORE will present its complete line of laser and optical receiver components for the transmission of video, voice and data signals over high-speed fiber optics, as well as components for wireless and Distributed Antenna System (DAS) applications. EMCORE will be meeting with customers, industry analysts and the media in our booth and invite you to contact us if you are interested in scheduling a meeting.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Emcore Corporation. (2019, February 25). OFC 2015: EMCORE to Highlight End-to-End DOCSIS 3.1 CATV Transmission Link. AZoOptics. Retrieved on November 21, 2024 from https://www.azooptics.com/News.aspx?newsID=20645.

  • MLA

    Emcore Corporation. "OFC 2015: EMCORE to Highlight End-to-End DOCSIS 3.1 CATV Transmission Link". AZoOptics. 21 November 2024. <https://www.azooptics.com/News.aspx?newsID=20645>.

  • Chicago

    Emcore Corporation. "OFC 2015: EMCORE to Highlight End-to-End DOCSIS 3.1 CATV Transmission Link". AZoOptics. https://www.azooptics.com/News.aspx?newsID=20645. (accessed November 21, 2024).

  • Harvard

    Emcore Corporation. 2019. OFC 2015: EMCORE to Highlight End-to-End DOCSIS 3.1 CATV Transmission Link. AZoOptics, viewed 21 November 2024, https://www.azooptics.com/News.aspx?newsID=20645.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.